home / stock / ontx / ontx news

ONTX News and Press, Onconova Therapeutics Inc. From 10/19/23

Stock Information
Company Name: Onconova Therapeutics Inc.
Stock Symbol: ONTX
Market: NASDAQ
Website: onconova.com
Menu
ONTX ONTX Quote ONTX Short ONTX News ONTX Articles ONTX Message Board
Get ONTX Alerts

News, Short Squeeze, Breakout and More Instantly...
ONTX - Promising Preclinical Narazaciclib Data Presented at MCL Meeting

Data for Mantle cell lymphoma (MCL) presented in Ireland on Oct. 7, 2023 Additional studies support broad potential, especially in cyclin-dependent cancers NEWTOWN, Pa., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the ȁ...
ONTX - Encouraging Rigosertib Data Presented at EADV as Late Breaker

NEWTOWN, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today ...

ONTX - Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress

NEWTOWN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that a la...

ONTX - Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference

NEWTOWN, Pa., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that Stev...
ONTX - Onconova Therapeutics, Inc. (ONTX) Q2 2023 Earnings Call Transcript

2023-08-10 21:08:05 ET Onconova Therapeutics, Inc. (ONTX) Q2 2023 Earnings Conference Call August 10, 2023, 4:30 PM ET Company Participants Bruce Mackle - LifeSci Advisors, IR Dr. Steve Fruchtman - President and CEO Dr. Victor Moyo - Consultant Chief Medical Offi...

ONTX - Onconova Therapeutics GAAP EPS of -$0.20 beats by $0.11, revenue of $0.06M misses by $0.01M

2023-08-10 16:26:07 ET Onconova Therapeutics press release ( NASDAQ: ONTX ): Q2 GAAP EPS of -$0.20 beats by $0.11 . Revenue of $0.06M (flat Y/Y) misses by $0.01M . For further details see: Onconova Therapeutics GAAP EPS of -$0.20 beats by $0.11, revenue o...

ONTX - Onconova Therapeutics Reports Corporate Update and Announces Second Quarter 2023 Financial Results

Anticipate topline results from the Phase 1 monotherapy and Phase 1/2 combination study with letrozole in Q4 2023 Plans are underway for a registrational trial with rigosertib in patients with RDEB-associated squamous cell carcinoma based on a constructive Type B FDA meeting held in Jun...
ONTX - Onconova Therapeutics to Provide Corporate Update and Announce Second Quarter 2023 Financial Results on August 10, 2023

NEWTOWN, Pa., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced ...

ONTX - Onconova Therapeutics Presents Preclinical Data on Narazaciclib at the 17th International Conference on Malignant Lymphoma

NEWTOWN, Pa., June 14, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova” or “the Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today presented ...

ONTX - Onconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual Meeting

NEWTOWN, Pa., June 05, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced the presentation of a Trials in Progres...
Previous 10 Next 10